Vision and Mission
SINGAPORE SCIENCES is a pioneering biopharmaceutical leader dedicated to transforming healthcare through research-driven, clinically tested solutions for chronic diseases. With a robust portfolio and cutting-edge pipeline spanning endocrinology (diabetes), immunology, and oncology, we leverage the most advanced innovations to develop premium therapeutic products.
Our mission is to redefine how diseases like diabetes, immune deficiencies, and cancer are prevented and treated, delivering hope and improved outcomes to patients worldwide.
Built upon a foundation grounded in scientific evidence, SINGAPORE SCIENCES is recognized as the leader in the field of novel healthcare research & product developments.
Each year SINGAPORE SCIENCES sponsors numerous research projects in leading institutes in Singapore and internationally on cutting edge research, including double-blind, placebo-controlled studies proving the safety and efficacy of its premier products.
Founders' Background
Patrick H.M. Loh
HonDSc, BBM, PBM
Singapore Distinguished Professor (Murdoch University, Australia)
Chartered Horticulturist, C Hort (UK)
Chartered Fintech Professional (CFtP)
Cofounder & Chairman
Professor Loh is Chairman & Co-Founder of SINGAPORE SCIENCES and SINOAGRO GROUP. A practising plant scientist, Professor Loh is one of the early pioneering bio-entrepreneurs in Singapore who successfully established the commercial application of biological and molecular techniques to plant and crop improvements in the agro-based industries in the ASEAN region.
Mr P.F. Chang
B.Eng (Bioengineering), Chartered Engineer, CEng (UK)
Cofounder & CEO
Mr Chang holds a Bachelor of Engineering degree with a Major in Bioengineering from Nanyang Technological University (NTU) in Singapore. In 2010, he established his first agrobiotech company to produce and supply biotech-derived therapeutic materials to healthcare corporations in Singapore. In 2012, he formulated and secured CPM approval from the Health Sciences Authority (HSA) of Singapore for the first High Active Ingredient Certified-Organic Cordyceps capsule product and trademarked in Singapore (2012).
Dr. Tan Chee Eng
SINGAPORE SCIENCES Medical Specialist Adviser
Consultant Physician & Endocrinologist MBBA, MMed (Int Med) FAMS (S'pore), PhD (Glasgow)
Dr Tan Chee Eng is Consultant Endocrinologist at the renowned Gleneagles Medical Centre in Singapore. Before starting private practice at Gleneagles Medical Centre in 2004, he was the Head of Department of Endocrinology at the Singapore General Hospital (SGH) for 5 years. Whilst at SGH, he was responsible for starting up the first Lipid unit in Singapore and also pioneered the electronic medical record for diabetes mellitus consultation (DMCARE).
Our R&D Initiatives and Collaborators
Advisory Board Members
Each year SINGAPORE SCIENCES sponsors numerous research projects in leading institutes in Singapore and internationally on cutting edge research, including double-blind, placebo-controlled studies proving the safety and efficacy of its premier products.
Built upon a foundation grounded in scientific evidence, SINGAPORE SCIENCES is recognized as the leader in the field of novel healthcare research & product developments.
